YI earnings

Achieved First-Ever Annual Operating ProfitBottom Line Improved by RMB332.7 Million YoY in 2024Operating Expenses as a Percentage of Revenues Decreased 230 Basis Points YoY in 2024 Q4'24 Operating Expenses as a Percentage of Revenues Decreased 470 Basis Points YoYAchieved First-Ever Annual Positive Operating Cash FlowSHANGHAI, March 20, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. Four

SHANGHAI, Feb. 20, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2024 ended December 31, 2024, before the U.S. market opens on Thursday, March 20, 2025. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, March 20, 2025 (7:30 PM Beijing Time on the same day). Details for the conference call are as follows: Conference Topic: 111, Inc. Fourth Q

Maintained Operational Profitability for the Third Consecutive QuarterOperating Expenses as a Percentage of Revenues Decreased 160 Basis Points YoYHeld Positive Operating Cash Flow for Three Consecutive QuartersSHANGHAI, Nov. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Net revenues were RMB3.6 billion (US$513.1 million), remaining relatively flat compared to the same

SHANGHAI, Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that its release of unaudited financial results for the third quarter ended September 30, 2024, previously scheduled for Thursday, November 28, 2024, will now occur before the U.S. market opens on Wednesday, November 27, 2024. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Wednesday, November 27, 2024 (8:30 PM Beijing Time on the same day). Details for the conference call a

SHANGHAI, Oct. 18, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2024, before the U.S. market opens on Thursday, November 28, 2024. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, November 28, 2024 (8:30 PM Beijing Time on the same day). Details for the conference call are as follows: Conference Topic: 111, Inc. Third Quarter 2024 Earn

Maintained Operational Profitability for the Second Consecutive QuarterOperating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoYHeld Positive Operating Cash Flow for Two Consecutive QuartersSHANGHAI, Aug. 29, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights Net revenues were RMB3.4 billion (US$471.2 million) and gross segment profit (1) was RMB 207.6 million

SHANGHAI, July 29, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2024, before the U.S. market opens on Thursday, August 29, 2024. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, August 29, 2024 (7:30 PM Beijing Time on the same day). Details for the conference call are as follows: Conference Topic: 111, Inc. Second Quarter 2024 Earnings Co

Turned to Quarterly Operational Profitability for the First TimeOperating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoY to 5.8%Achieved Positive Operating Cash FlowSHANGHAI, May 23, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Net revenues were RMB3.5 billion (US$488.7 million) and Gross segment profit (1) was RMB 208.5 million (US$ 28.9 million). Due to

SHANGHAI, April 30, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2024, before the U.S. market opens on Thursday, May 23, 2024. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, May 23, 2024 (7:30 PM Beijing Time on the same day). Details for the conference call are as follows: Conference Topic: 111, Inc. First Quarter 2024 Earnings Conference CallRegistration Link: https:/

SHANGHAI, March 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Highlights Net revenues were RMB4.1 billion (US$578.7 million), representing a decrease of 1.0% year-over-year.Gross segment profit (1) was RMB 214.3 million (US$ 30.2 million), decreased by 15.5% year-over-year.Total operating expenses were RMB420.8 million (US$59.3 million), compared to RMB361.9 million in the same quarter of last y

SHANGHAI, March 1, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2023 ended December 31, 2023, before the U.S. market opens on Thursday, March 21, 2024. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, March 21, 2024 (7:30 PM Beijing Time on the same day). Details for the conference call are as follows: Conference Topic: 111, Inc. Fourth Quarter and Fiscal Year 2023 Unaud

SHANGHAI, Nov. 30, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Highlights Net revenues were RMB3.7 billion (US$502.4 million), representing an increase of 9.5% year-over-year.Gross segment profit (1) was RMB 190.6 million (US$ 26.1 million), decreased by 5.6% year-over-year.Total operating expenses were RMB271.0 million (US$37.2 million), compared to RMB282.7 million in the same quarter of last year.  As a percent

SHANGHAI, Aug. 24, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Highlights Net revenues were RMB3.5 billion (US$479.6 million), representing an increase of 14.5% year-over-year.Gross segment profit(1) increased by 8.3% year-over-year, with B2B segment profit increasing by 11.6% year-over-year.Total operating expenses were RMB249.3million (US$34.4million), compared to RMB271.7 million in the same quarter of last year. A

SHANGHAI, July 31, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2023, before the U.S. market opens on Thursday, August 24, 2023. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, August 24, 2023 (7:30 PM Beijing Time on the same day). Details for the conference call are as follows: Conference Topic: 111, Inc. Second Quarter 2023 Earnings Conference CallRegistration Link: ht

SHANGHAI, June 15, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the first quarter ended March 31, 2023. First Quarter 2023 Highlights Net revenues were RMB3.7 billion (US$538.3 million), representing an increase of 23.9% year-over-year.Gross segment profit (1) increased by 22.7% year-over-year, with B2B segment profit increasing by 25.5% year-over-year.Total operating expenses were RMB257.9 million (US$37.6 million), compared to RMB294.7 million in the same quarter of last year

SHANGHAI, May 25, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2023, before the U.S. market opens on Thursday, June 15, 2023. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, June 15, 2023 (7:30 PM Beijing Time on the same day). Details for the conference call are as follows: Conference Topic: 111, Inc. First Quarter 2023 Earnings Conference CallRegistration Link: https://

SHANGHAI, March 23, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2022. Fourth Quarter 2022 Highlights Net revenues were RMB4.1 billion (US$601.4 million), representing an increase of 19.9% year-over-year.Gross segment profit (1) increased by 23.8% year-over-year, with B2B segment profit increasing by 31.5% year-over-year.Loss from operations was RMB108.4 million (US$15.7 million), compared to RMB104.7 million in the same qua

SHANGHAI, March 2, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2022 ended December 31, 2022, before the U.S. market opens on Thursday, March 23, 2023. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, March 23, 2023 (7:30 PM Beijing Time on the same day). Details for the conference call are as follows: Conference Topic: 111, Inc. Fourth Quarter and Fiscal Year 2022 Unaudi

SHANGHAI, Dec. 1, 2022 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Key Results Net revenues were RMB3.35 billion (US$470.8 million), representing an increase of 0.1% year-over-year.Gross segment profit (1) increased by 21.6% year-over-year, with B2B segment profit increasing by 26.9% year-over-year.Total operating expenses were RMB282.7 million (US$39.7 million), compared to RMB341.4 million in the same quarter of last y

SHANGHAI, Nov. 8, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2022, before the U.S. market opens on Thursday, December 1, 2022. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, December 1, 2022 (8:30 PM Beijing Time on the same day). Details for the conference call are as follows: Conference Topic: 111, Inc. Third Quarter 2022 Earnings Conference Call Registration Lin

SHANGHAI, Aug. 25, 2022 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Key Results Net revenues were RMB3.04 billion (US$453.4 million), representing an increase of 0.4% year-over-year.Gross segment profit (1) increased by 42.6% year-over-year, with B2B segment profit increasing by 55.1% year-over-year.Total operating expenses were RMB271.7 million (US$40.6 million), compared to RMB323.4 million in the same quarter of last ye

SHANGHAI, Aug. 5, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2022, before the U.S. market opens on Thursday, August 25, 2022. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, August 25, 2022 (7:30 PM Beijing Time on the same day). Details for the conference call are as follows: Conference Topic: 111, Inc. Second Quarter 2022 Earnings Conference Call Registration Link: ht

SHANGHAI, June 16, 2022 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the first quarter ended March 31, 2022. First Quarter 2022 Highlights Net revenues were RMB2.98 billion (US$470.5 million), representing an increase of 14.9% year-over-year.Gross segment profit (1) increased by 66.3% year-over-year, with B2B segment profit increasing by 90.7% year-over-year.Total operating expenses were RMB294.7 million (US$46.5 million), compared to RMB289.0 million in the same quarter of last yea

SHANGHAI, May 26, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2022, before the U.S. market opens on Thursday, June 16, 2022. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, June 16, 2022 (7:30 PM Beijing Time on the same day). Details for the conference call are as follows: Conference Topic: 111, Inc. First Quarter 2022 Earnings Conference CallRegistration Link: http://a

SHANGHAI, March 17, 2022 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2021. Fourth Quarter 2021 Highlights Net revenues were RMB3.46 billion (US$543.1 million), representing an increase of 30.9% year-over-year. Gross segment profit (1) increased by 98% year-over-year, with B2B segment profit increasing by 133% year-over-year. Non-GAAP loss from operations (2) was RMB76.9 million (US$12.1 million), compared to RMB112.3million in t

SHANGHAI, Feb. 22, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2021 ended December 31, 2021, before the U.S. market opens on Thursday, March 17, 2022. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, March 17, 2022 (7:30 PM Beijing Time on the same day). Details for the conference call are as follows: Event Title: 111, Inc. Fourth Quarter and Fiscal Year 2021 Unaudited F

SHANGHAI, Nov. 19, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the third quarter ended September 30, 2021. Third Quarter 2021 Highlights Net revenues were RMB3.35 billion (US$519.3 million), representing an increase of 41.6% year-over-year. Service revenue increased 106% year-over-year, among which B2B service revenue increased 336% year-over-year. Gross profit(1) increased 85% year-over-year and gross margin improved from 3.8% to 5.0%, among which gross profit for the B2B seg

SHANGHAI, Oct. 28, 2021 /PRNewswire/ – 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2021, before the U.S. market opens on Friday, November 19, 2021. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Friday, November 19, 2021 (7:30 PM Beijing Time on the same day). Details for the conference call are as follows: Event Title:                         111, Inc. Third Quarter 2021 Earnings Conference Cal

SHANGHAI, Aug. 27, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the second quarter ended June 30, 2021. Second Quarter 2021 Highlights Net revenues were RMB3.0 billion (US$468.4 million), representing an increase of 86.5% year-over-year. Operating expenses(1) were RMB323.4 million (US$50.1 million), representing an increase of 82.2% year-over-year. Operating expenses accounted for 10.7% of net revenue this quarter as compared to 10.9% in the same quarter of last year. Technolog

SHANGHAI, Aug. 9, 2021 /PRNewswire/ – 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2021, before the U.S. market opens on Friday, August 27, 2021. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Friday, August 27, 2021 (7:30 PM Beijing Time on the same day). Details for the conference call are as follows: Event Title:                       111, Inc. Second Quarter 2021 Earnings Conference CallRegistrat